Medication-related osteonecrosis of the jaw; what should we do as prosthodontists? [electronic resource]
- Journal of prosthodontic research Oct 2016
- 229-230 p. digital
Publication Type: Letter
2212-4632
10.1016/j.jpor.2016.01.004 doi
Animals Antibodies, Monoclonal--adverse effects Bisphosphonate-Associated Osteonecrosis of the Jaw--etiology Bone Density Conservation Agents--adverse effects Bone Marrow Cells--metabolism Denosumab--adverse effects Diphosphonates--adverse effects Humans Jaw Macrophages Mice Monocytes Prosthodontics--methods RANK Ligand--immunology Tartrate-Resistant Acid Phosphatase--metabolism